Clinical trial sponsors have long found a disconnect between the country’s potential and reality as a research location. Recently, however, Chinese authorities have been overhauling its clinical trial and drug processes, which now make it possible to get drugs approved in China using data generated overseas, and improved the process for sponsors that run trials in the country. (PMLIVE)